ACHC
Income statement / Annual
Last year (2025), Acadia Healthcare Company Inc's total revenue was $3.31 B,
an increase of 5.04% from the previous year.
In 2025, Acadia Healthcare Company Inc's net income was -$1.10 B.
See Acadia Healthcare Company Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$3.31 B |
$3.15 B |
$2.93 B |
$2.61 B |
$2.31 B |
$2.09 B |
$2.01 B |
$3.01 B |
$2.84 B |
$2.81 B |
| Cost of Revenue |
$2.73 B
|
$2.44 B
|
$2.25 B
|
$100.20 M
|
$90.70 M
|
$87.24 M
|
$1.19 B
|
$1.78 B
|
$1.65 B
|
$1.66 B
|
| Gross Profit |
$583.44 M
|
$711.98 M
|
$682.61 M
|
$2.51 B
|
$2.22 B
|
$2.00 B
|
$815.49 M
|
$1.23 B
|
$1.19 B
|
$1.15 B
|
| Gross Profit Ratio |
0.18
|
0.23
|
0.23
|
0.96
|
0.96
|
0.96
|
0.41
|
0.41
|
0.42
|
0.41
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$195.48 M
|
$189.71 M
|
$176.01 M
|
$1.60 B
|
$1.42 B
|
$1.31 B
|
$118.45 M
|
$307.71 M
|
$273.00 M
|
$258.83 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$35.49 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$195.48 M
|
$189.71 M
|
$176.01 M
|
$1.60 B
|
$1.42 B
|
$1.31 B
|
$153.94 M
|
$307.71 M
|
$273.00 M
|
$258.83 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$445.60 M
|
$390.16 M
|
$690.32 M
|
$0.00
|
-$34.51 M
|
-$24.27 M
|
-$48.32 M
|
| Operating Expenses |
$195.48 M
|
$189.71 M
|
$176.01 M
|
$2.04 B
|
$1.81 B
|
$2.00 B
|
$153.94 M
|
$821.04 M
|
$747.84 M
|
$706.49 M
|
| Cost And Expenses |
$2.92 B
|
$2.63 B
|
$2.42 B
|
$2.14 B
|
$1.90 B
|
$2.09 B
|
$1.35 B
|
$2.60 B
|
$2.40 B
|
$2.37 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$876.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
$138.86 M
|
$116.37 M
|
$82.13 M
|
$69.76 M
|
$76.99 M
|
$158.11 M
|
$187.33 M
|
$185.41 M
|
$176.01 M
|
$181.33 M
|
| Depreciation & Amortization |
$189.25 M
|
$149.60 M
|
$132.35 M
|
$117.77 M
|
$106.72 M
|
$95.26 M
|
$87.92 M
|
$158.83 M
|
$143.01 M
|
$135.10 M
|
| EBITDA |
-$737.83 M |
$607.84 M |
$189.11 M |
$561.67 M |
$459.47 M |
$437.16 M |
$402.02 M |
$385.88 M |
$580.89 M |
$580.25 M |
| EBITDA Ratio |
-0.22
|
0.19
|
0.06
|
0.22
|
0.2
|
0.21
|
0.2
|
0.13
|
0.2
|
0.21
|
| Operating Income Ratio |
0.12
|
0.17
|
0.17
|
0.18
|
0.18
|
0
|
0.33
|
0.14
|
0.15
|
0.16
|
| Total Other Income/Expenses Net |
-$1.45 B
|
-$180.40 M
|
-$531.96 M
|
-$93.55 M
|
-$138.71 M
|
$183.80 M
|
-$583.16 M
|
-$581.70 M
|
-$201.08 M
|
-$412.19 M
|
| Income Before Tax |
-$1.07 B
|
$341.88 M
|
-$25.36 M
|
$374.14 M
|
$275.76 M
|
$183.80 M
|
$78.40 M
|
-$168.95 M
|
$236.80 M
|
$32.96 M
|
| Income Before Tax Ratio |
-0.32
|
0.11
|
-0.01
|
0.14
|
0.12
|
0.09
|
0.04
|
-0.06
|
0.08
|
0.01
|
| Income Tax Expense |
$25.98 M
|
$77.40 M
|
-$9.70 M
|
$94.11 M
|
$67.56 M
|
$40.61 M
|
$25.09 M
|
$6.53 M
|
$37.21 M
|
$28.78 M
|
| Net Income |
-$1.10 B
|
$255.61 M
|
-$21.67 M
|
$273.14 M
|
$190.64 M
|
-$672.13 M
|
$108.92 M
|
-$175.75 M
|
$199.84 M
|
$6.14 M
|
| Net Income Ratio |
-0.33
|
0.08
|
-0.01
|
0.1
|
0.08
|
-0.32
|
0.05
|
-0.06
|
0.07
|
0
|
| EPS |
-12.16 |
2.79 |
-0.24 |
3.05 |
2.15 |
-7.65 |
1.24 |
-2.01 |
2.3 |
0.07 |
| EPS Diluted |
-12.16 |
2.78 |
-0.24 |
2.98 |
2.1 |
-7.65 |
1.24 |
-2.01 |
2.3 |
0.07 |
| Weighted Average Shares Out |
$90.71 M
|
$91.62 M
|
$90.95 M
|
$89.68 M
|
$88.77 M
|
$87.88 M
|
$87.61 M
|
$87.29 M
|
$86.95 M
|
$85.70 M
|
| Weighted Average Shares Out Diluted |
$90.71 M
|
$92.06 M
|
$90.95 M
|
$91.56 M
|
$90.79 M
|
$88.60 M
|
$87.82 M
|
$87.29 M
|
$87.06 M
|
$85.97 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
